Serial 79345693
Live / Registered — Registered (as of 04 Jul 2023)
What this means for you
Registered since 04 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79345693
- Registration number
- 7095580
- Mark type
- Design / logo
- Filed
- 19 May 2022
- Published for opposition
- 18 Apr 2023
- Registered
- 04 Jul 2023
- Attorney of record
- Gregory J. Chinlund
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and veterinary preparations for use in the treatment of cancer, autoimmune diseases, and medical conditions arising from transplantation and gene therapy, and for use with transplantation and gene therapy; pharmaceutical preparations, namely, preparations for cleaving human antibodies; pharmaceutical preparations and veterinary preparations, namely, enzyme preparations and sterilizing preparations; sanitary preparations, namely, chemical enzyme preparations and sterilizing preparations; medicines for diagnosing, preventing, and treating cancer and autoimmune diseases for human and veterinary purposes; pharmaceutical preparations for elimination of antibodies for therapeutic purposes in immune related diseases and conditions; enzymes for medical and veterinary purposes
Owner
- HANSA BIOPHARMA AB, SE
- HANSA BIOPHARMA AB, SE
- HANSA BIOPHARMA AB, SE
Prosecution history
- 31 Oct 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 10 Oct 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 10 Oct 2023 — FINAL DISPOSITION PROCESSED
- 04 Oct 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 04 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 18 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Apr 2023 — PUBLISHED FOR OPPOSITION
- 29 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Mar 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Oct 2022 — REFUSAL PROCESSED BY IB